YINLIN JACK CHEN - 10 Aug 2023 Form 4 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role
SVP, Finance
Signature
/s/Lillian Smith, Attorney-in-Fact
Issuer symbol
ALLO
Transactions as of
10 Aug 2023
Net transactions value
$0
Form type
4
Filing time
14 Aug 2023, 19:59:16 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALLO Common Stock Award $0 +11,401 +15% $0.000000 88,881 10 Aug 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALLO Stock Option (Right to Buy) Award $0 +39,160 $0.000000 39,160 10 Aug 2023 Common Stock 39,160 $4.21 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the stock option shall vest on August 10, 2024, and the remaining shares shall vest in 36 equal monthly installments thereafter.